World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
21306
World Ranking
17632
National Ranking
923

Martin Stanulla publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Martin Stanulla sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 373 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Martin Stanulla D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Martin Stanulla sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Martin Stanulla is affiliated with Hannover Medical School in Germany and has a significant body of work in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research mainly focuses on hematological malignancies and pediatric oncology, with a notable emphasis on leukemia studies.

The scientist's published work extensively covers several subfields including Public Health, Environmental and Occupational Health, Hematology, Molecular Biology, Pediatrics, Perinatology and Child Health, and Genetics.

Major topics of research include:

  • Acute Lymphoblastic Leukemia research
  • Acute Myeloid Leukemia Research
  • Childhood Cancer Survivors' Quality of Life
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Epigenetics and DNA Methylation
  • CAR-T cell therapy research

Frequent publication venues for Stanulla's work are diverse and include:

  • HemaSphere
  • Blood
  • Klinische Pädiatrie
  • Blood Advances
  • Leukemia

Among key research papers, the following are notable:

  • "Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment" (2020) published in European Journal of Cancer
  • "The KMT2A recombinome of acute leukemias in 2023" (2023) published in Leukemia
  • "Environmental Risk Factors for Childhood Acute Lymphoblastic Leukemia: An Umbrella Review" (2022) published in Cancers
  • "The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia" (2021) published in Cancers
  • "Exploiting the Therapeutic Interaction of WNT Pathway Activation and Asparaginase for Colorectal Cancer Therapy" (2020) published in Cancer Discovery

Stanulla collaborates frequently with a group of co-authors including Gunnar Cario, Martin Schrappe, Jean-Pierre Bourquin, Anja Möricke, and Cornelia Eckert, contributing to a broad network of research within leukemia and pediatric oncology.

Best Publications

  • Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

    Valentino Conter;Claus R. Bartram;Maria Grazia Valsecchi;Andre Schrauder

  • Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

    Anja Möricke;Alfred Reiter;Martin Zimmermann;Helmut Gadner

  • The MLL recombinome of acute leukemias in 2017

    C Meyer;T Burmeister;D Gröger;G Tsaur

  • Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

    A Möricke;M Zimmermann;A Reiter;G Henze

  • The MLL recombinome of acute leukemias in 2013

    C. Meyer;J. Hofmann;T. Burmeister;D. Gröger

  • Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia.

    T Flohr;T Flohr;A Schrauder;G Cazzaniga;R Panzer-Grümayer

  • Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias

    Chen Shochat;Noa Tal;Noa Tal;Obul R. Bandapalli;Obul R. Bandapalli;Chiara Palmi

  • Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome

    Dani Bercovich;Ithamar Ganmore;Linda M. Scott;Gilad Wainreb

  • Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance

    Laura Bonapace;Beat C. Bornhauser;Maike Schmitz;Gunnar Cario

  • Estrogen Metabolism and Risk of Breast Cancer: A Prospective Study of the 2:16α-Hydroxyestrone Ratio in Premenopausal and Postmenopausal Women

    Paola Muti;H. Bradlow;Andrea Micheli;Vittorio Krogh

  • Thiopurine Methyltransferase (TPMT) Genotype and Early Treatment Response to Mercaptopurine in Childhood Acute Lymphoblastic Leukemia

    Martin Stanulla;Elke Schaeffeler;Thomas Flohr;Gunnar Cario

  • Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia.

    Stephen Breit;Martin Stanulla;Thomas Flohr;Martin Schrappe

  • Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk

    Amy L. Sherborne;Fay J. Hosking;Rashmi B. Prasad;Rajiv Kumar

  • Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group

    Libi Hertzberg;Libi Hertzberg;Libi Hertzberg;Elena Vendramini;Ithamar Ganmore;Ithamar Ganmore;Giovanni Cazzaniga

  • Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol.

    Gunnar Cario;Martin Zimmermann;Renja Romey;Stefan Gesk

  • The MLL recombinome of acute leukemias.

    C. Meyer;B. Schneider;S. Jakob;S. Strehl

  • Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study

    Martin Stanulla;Martin Schrappe;Annette Müller Brechlin;Martin Zimmermann

  • Childhood cancer predisposition syndromes : A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology

    Tim Ripperger;Stefan S. Bielack;Arndt Borkhardt;Ines B. Brecht;Ines B. Brecht

  • IKZF1plus Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

    Martin Stanulla;Elif Dagdan;Marketa Zaliova;Anja Möricke

  • Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia

    Gunnar Cario;Martin Stanulla;Bernard M. Fine;Oliver Teuffel

Frequent Co-Authors

Martin Schrappe
Martin Schrappe Kiel University
Martin Zimmermann
Martin Zimmermann Hannover Medical School
Andreas E. Kulozik
Andreas E. Kulozik Heidelberg University
Karl Welte
Karl Welte University of Tübingen
Martina U. Muckenthaler
Martina U. Muckenthaler Heidelberg University
Giovanni Cazzaniga
Giovanni Cazzaniga University of Milano-Bicocca
Claus R. Bartram
Claus R. Bartram Heidelberg University
Jochen Harbott
Jochen Harbott University of Giessen
Andrea Biondi
Andrea Biondi University of Milano-Bicocca
Jan Trka
Jan Trka Charles University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine opens doors to a variety of online degree options that can support or complement your medical journey. For registered nurses interested in advanced practice, rn to np bridge programs offer a flexible path to nurse practitioner roles, often accommodating busy schedules.

Alternatively, professionals looking to integrate nutrition into patient care can benefit from an online nutritionist degree, ideal for those aiming to provide holistic support in medical settings.

If your ambitions include healthcare management, consider a cahme accredited online mha program. This pathway is recognized for its quality and can help launch careers in hospital or clinic administration.

Lastly, RNs aiming to expand their credentials quickly may find rn to bsn online programs without clinicals especially convenient, as these allow advancement without the need for additional clinical hours.

Whether you’re pursuing direct patient care or healthcare leadership, these online degree options provide accessible stepping stones on your path in medicine.

Best Scientists Citing Martin Stanulla

Trending Scientists

Recently Published Articles